Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

High-flying IPOs from companies with no profits and no products characterized the dot-com boom of the 90s. Are we on the verge of revisiting those days thanks to, of all things, nanotechnology?

That’s the question asked in today’s New York Times. At least five nanotechnology companies are considering going public this year. Nanosys, based in Palo Alto, CA, is the first of the these, and its SEC filings reveal the company has no profits and no plans to market any product until 2006. To be fair, the story does point out that nanotech startups bear a greater resemblance to biotech companies, with much larger up-front investment requirements to pay for the research and expert personnel needed to develop those products. (Technology Review recently profiled Nanosys.)

But with biotech stocks in a slump as promised products fail to materialize, should investors be as eager to jump on this newest tech bandwagon?

0 comments about this story. Start the discussion »

Reprints and Permissions | Send feedback to the editor

From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me